FDA Clears iLet Bionic Pancreas for Patients With Type 1 Diabetes
The FDA has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for persons 6 years of age and older with type 1 diabetes.
Stay updated with breaking news from Decision Software. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for persons 6 years of age and older with type 1 diabetes.
Announced by the US FDA on May 19, 2023, the clearance of the iLet ACE Pump and the iLet Dosing Decision Software, when combined with a compatible CGM, will form the iLet Bionic Pancreas.
/PRNewswire/ -- Today, the U.S. Food and Drug Administration cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years...
The FDA has cleared a next-generation insulin pump and software combination that provides greater automation than current "artificial pancreas" systems.
System does away with need for carb counting